aHUS trial watch 17- NM8074
Another trial of a complement inhibitor for aHUS treatment has been announced , it is for something currently called NM8074. Full…
Another trial of a complement inhibitor for aHUS treatment has been announced , it is for something currently called NM8074. Full…
This time last year a couple of dozen people with an interest in global aHUS advocacy were discussing and deciding on…
Sometimes it can be confusing being an aHUS patient. Even to knowing whether you are really an aHUS patient. Even if…
Listening to some aHUS people on social media there is a sense that all are not satisfied with what is happening…
aHUS: Rare Blood Disorder This is a chat Global Action had with ChatGPT about aHUS. ChatGPT is a very new online…
- An Hematopoietic Stem Cell Transplant (HSCT) is a way to treat some malignant and benign diseases. The transplant replaces disease…
It is now over two years ago that Global Action began a major study of the aHUS Diagnosis Process, it is…
So adverse events are being reported. In USA over 4500 per year on average for eculizumab are reported to the FDA…
aHUS patients in clinical trials are monitored for adverse events and personal outcomes experience while on treatment. Adverse events have been…